[go: up one dir, main page]

AU2015905047A0 - Methods of treating or alleviating mental disorders and associated symptoms - Google Patents

Methods of treating or alleviating mental disorders and associated symptoms

Info

Publication number
AU2015905047A0
AU2015905047A0 AU2015905047A AU2015905047A AU2015905047A0 AU 2015905047 A0 AU2015905047 A0 AU 2015905047A0 AU 2015905047 A AU2015905047 A AU 2015905047A AU 2015905047 A AU2015905047 A AU 2015905047A AU 2015905047 A0 AU2015905047 A0 AU 2015905047A0
Authority
AU
Australia
Prior art keywords
treating
methods
mental disorders
associated symptoms
alleviating mental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015905047A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deakin University
Florey Institute of Neuroscience and Mental Health
Original Assignee
Deakin University
Florey Institute of Neuroscience and Mental Health
Filing date
Publication date
Application filed by Deakin University, Florey Institute of Neuroscience and Mental Health filed Critical Deakin University
Publication of AU2015905047A0 publication Critical patent/AU2015905047A0/en
Priority to ES16870056T priority Critical patent/ES2952610T3/en
Priority to US15/780,913 priority patent/US11197840B2/en
Priority to PCT/IB2016/001853 priority patent/WO2017093807A1/en
Priority to EP16870056.5A priority patent/EP3423049B1/en
Priority to AU2016364670A priority patent/AU2016364670B2/en
Priority to US17/455,384 priority patent/US20220117925A1/en
Abandoned legal-status Critical Current

Links

AU2015905047A 2015-12-04 2015-12-04 Methods of treating or alleviating mental disorders and associated symptoms Abandoned AU2015905047A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES16870056T ES2952610T3 (en) 2015-12-04 2016-12-02 Methods to treat or alleviate mental disorders and associated symptoms
US15/780,913 US11197840B2 (en) 2015-12-04 2016-12-02 Methods of treating or alleviating mental disorders and associated symptoms
PCT/IB2016/001853 WO2017093807A1 (en) 2015-12-04 2016-12-02 Methods of treating or alleviating mental disorders and associated symptoms
EP16870056.5A EP3423049B1 (en) 2015-12-04 2016-12-02 Methods of treating or alleviating mental disorders and associated symptoms
AU2016364670A AU2016364670B2 (en) 2015-12-04 2016-12-02 Methods of treating or alleviating mental disorders and associated symptoms
US17/455,384 US20220117925A1 (en) 2015-12-04 2021-11-17 Methods of treating or alleviating mental disorders and associated symptoms

Publications (1)

Publication Number Publication Date
AU2015905047A0 true AU2015905047A0 (en) 2015-12-17

Family

ID=

Similar Documents

Publication Publication Date Title
IL259751B (en) Polycyclic compounds and use thereof in the treatment of immune disorders
EP3185876A4 (en) Compositions and methods for treatment of neurological disorders
GB2542155B (en) Use of cannabidiol in the treatment of mental disorders
EP3152237A4 (en) Methods and compositions for treatment of disorders with follistatin polypeptides
IL259861A (en) Methods and compositions for the treatment of seizure-related disorders
EP3183005A4 (en) Methods and compositions for the treatment of metabolic disorders
EP3154570A4 (en) Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders
EP3377090A4 (en) Methods for treatment of bile acid-related disorders
EP3104776A4 (en) Diagnosis and treatment of respiratory disorders
ZA201901055B (en) Treatment and prevention of sleep disorders
EP3347000A4 (en) Methods for treating skin disorders and conditions utilizing haptens
EP3197440A4 (en) Treatment of anxiety disorders and autism spectrum disorders
IL275654A (en) Methods of treating disorders associated with castor
IL263477A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders
EP3041577A4 (en) Treatment and prevention of autism and autism spectrum disorders
EP3258930A4 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
GB201607388D0 (en) Treatment of impulsivity-related disorders
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
SMT202400084T1 (en) Composition for the prevention and/or treatment of allergy symptoms
EP3151824A4 (en) Methods of treating neurodevelopmental diseases and disorders
EP3131635A4 (en) Compositions and methods for the treatment or prevention of neurodegenerative disorders
EP3229908A4 (en) Gdnf induction for the treatment of retinal disorders
EP2999473A4 (en) Treatment of neurological and other disorders
AU2015905047A0 (en) Methods of treating or alleviating mental disorders and associated symptoms
HK40066377A (en) Compositions and methods for treatment of neurological disorders